Resources

Increasing PTS using multimodal data

Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.

Speakers: Iker Huerga
SVP, Life Sciences Strategy, Tempus

Leora Horn, MD
Global Clinical Head for Lung Cancer & Lung Cancer Strategy, AstraZeneca

Watch replay

Multimodal data drives biomarker innovation

We spoke with Gilead experts to learn how the company uses multimodal data to achieve early successes in translational biomarker research and discovery.

Speakers: Ryan Fukushima
Chief Operating Officer, Tempus

Scott Patterson, PhD
Vice President of Biomarker Sciences, Gilead Sciences, Inc.

Shahed Iqbal, PhD
Senior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc.

Watch replay

The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting

Speakers: Ezra Cohen, MD, FRCPSC, FASCO
Chief, Division of Hematology-Oncology, UC San Diego Moores Cancer Center

Mary J. Fidler, MD
Medical Oncology Section Chief, Rush Medical Center

Wade T. Iams, MD, MSCI
Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center

Calvin Chao, MD
SVP, Medical Affairs, Tempus

James L. Chen, MD
SVP, Cancer Informatics, Tempus

Watch replay

Personalize mental health with Pharmacogenomics

In this on-demand webinar, Dr. Brian Forsythe shares how he incorporates PGx testing into clinical practice to inform treatment decisions for patients.

Speakers: Brian C. Forsythe, D.O.; Dallas Psychiatry & TMS Center, Joseph D. Stanton, PhD - Associate Director, Medical Affairs

Watch replay

The next evolution in drug development

We spoke with Janssen’s Dr. Najat Khan to find out how the company is applying advanced AI algorithms to RWD – with groundbreaking results.

Speakers: Najat Khan, Ph.D., Chief Data Science Officer and Global Head, Strategy and Operations, Janssen Research & Development; Ryan Fukushima, Chief Operating Officer, Tempus

Watch replay

Harnessing real world genomics data to power precision medicine

Explore the successes in the Vanderbilt-Tempus partnership using the Epics Genomics Module

Speakers: Dr. James Chen, SVP Cancer Informatics, Tempus; Dr. Ben Park, Director, Professor of Medicine, Director of Precision Oncology, Vanderbilt University Medical Center; Dr. Travis Osterman, Director Cancer Clinical Informatics, Vanderbilt-Ingram Cancer Center

Watch replay

Tempus + TriHealth: Epic Genomics Module

Redefining what’s possible - Genomic data, actionable results, improved outcomes

Speakers: James Chen, MD, Tempus; Karen Huelsman, MS, LGC, TriHealth; Leah Vasiliadis, TriHealth; Patrick Mergler, MBA, PMP, CPHIMS, Tempus

Watch replay

Operational processes and challenges in germline testing

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 6

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Role of ctDNA in germline testing

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 5

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Identification of patients for germline testing

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 4

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay